Cellular kinetics in Barrett's epithelium carcinogenic sequence: Roles of apoptosis, bcl-2 protein, and cellular proliferation

Modern Pathology

Volumn 10, Issue 12, 1997, Pages 1201-1208

  Lauwers, Gregory Y ^a,c   Kandemir, Olcay ^b   Kubilis, Paul S ^a   Scott, Gregory V ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b ERCIYES UNIVERSITY   (Turkey)

^c UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

Apoptosis; Barrett's esophagus; bcl 2 protein; Carcinogenesis; Ki 67

Indexed keywords

KI 67 ANTIGEN; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; BARRETT ESOPHAGUS; CANCER GRADING; CARCINOGENESIS; CELL KINETICS; CELL PROLIFERATION; CONTROLLED STUDY; DYSPLASIA; ESOPHAGUS CARCINOMA; HUMAN; HUMAN TISSUE; METAPLASIA; PRIORITY JOURNAL;

ADENOCARCINOMA; APOPTOSIS; BARRETT ESOPHAGUS; EPITHELIUM; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0345646455     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Haggitt R. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol 1994;25:982-93.
2. Winters C, Spurling TJ, Chobanian, Curtis DJ, Esposito RL, Hacker JK, et al. Barrett's esophagus: a prevalent occult complication of gastroesophageal reflux disease. Gastroenterology 1987;92:118-24.
3. Hamilton SR. Pathogenesis of columnar cell-lined (Barrett's) esophagus. In: Speckler SJ, Goyel RK, editors. Barrett's esophagus: pathophysiology, diagnosis, and management. New York: Elsevier; 1985. p. 29-37.
4. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287-9.
5. Reid BJ. Barrett's esophagus: a human model of neoplastic progression. Cancer Res 1993;34:608-9.
6. Reid BJ, Sandez CA, Blount PL, Levine DS. Barrett's esophagus: cell cycle abnormalities in advancing stages of neoplastic progression. Gastroenterology 1993;105:119-29.
7. Huang Y, Boynton RF, Blount PL, Silverstein RJ, Yin J, Tong Y, et al. Loss of heterozygosity involves multiple tumor suppression genes in human esophageal cancers. Cancer Res 1992;52:6525-30.
8. McDonnell TJ. Cell division versus cell death: a functional model of multistep neoplasia. Mol Carcinog 1993;8:209-13.
9. Eastwood GL. Gastrointestinal epithelial renewal. Gastroenterology 1977:72:962-75.
10. Lebda-Columbano GM, Columbano A. Apoptosis and hepatocarcinogenesis. In: Tomei LD, Cope FO, editors. Apoptosis: the molecular basis of cell death. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1991. p. 101-19.
11. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
12. Hollander M, Wolfe DA. Nonparametric statistical methods. New York: Wiley; 1973. p. 138-84.
13. Gray MR, Hall PA, Nash J, Ansari B, Lane DP, Kingsnorth AN. Epithelial proliferation in Barrett's esophagus by proliferating cell nuclear antigen immunolocalization. Gastroenterology 1992;103:1769-76.
14. Hong MK, Laskin WB, Herman BE, Johnston MH, Vargo JJ, Steinberg SM, et al. Expansion of the Ki-67 proliferative compartment correlates with degree of dyplasia in Barrett's esophagus. Cancer 1995;75:423-9.
15. Gillen P, McDermott M, Grehan D, Hourihane DB, Hennessy TPJ. Proliferating cell nuclear antigen in the assessment of Barrett's mucosa. Br J Surg 1994;81:1766-8.
16. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell-cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710-5.
17. Korsmeyer SJ. bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992;80:879-86.
18. Oren M. The involvement of oncogenes and tumor suppressor genes in the control of apoptosis. Cancer Metastasis Rev 1992;11:141-8.
19. Hockenberry DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ. bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci U S A 1991;88:6961-5.
20. LeBrun DP, Warnke RA, Cleary ML. Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. Am J Pathol 1993;142:743-53.
21. Bronner MP, Culin C, Reed JC, Furth EE. The bcl-2 protooncogene and the gastrointestinal epithelial tumor progression model. Am J Pathol 1995;146:20-6.
22. Lauwers GY, Scott GV, Hendricks J. Immunohistochemical evidence of aberrant bcl-2 protein expression in gastric epithelial dysplasia. Cancer 1994;73:2900-4.
23. Lu QL, Abel P, Foster CS, Lalani E N. bcl-2: role in epithelial differentiation and oncogenesis. Hum Pathol 1996;27:102-10.
24. Goldblum JR, Rice TW. bcl-2 protein expression in the Barrett's metaplasia-dysplasia-carcinoma sequence. Mod Pathol 1995;8:866-9.
25. Clark MR, Kim R, Chang T, Stetler-Stevenson WG, Reynolds JC. Barrett's metaplasia and Barrett's adenocarcinoma of the esophagus: MIB-1, bcl-2, type IV collagen, type IV collagenase, and cathepsin D expression [abstract]. Mod Pathol 1995;8:59A.
26. Lauwers GY, Karpeh M, Scott GV. Immunohistochemical evaluation of bcl-2 protein expression in gastric adenocarcinomas. Cancer 1995;75:2209-13.
27. Klein RF, Vollmers HP, Müller-Hermelink HK. Different expression of bcl-2 in diffuse and intestinal type stomach carcinomas. Oncol Rep 1996;3:825-8.
28. Hall PA, Coates PJ, Ansari B, Hopwood D. Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. J Cell Science 1994;107:3569-77.
29. Potten CS. The significance of spontaneous and induced apoptosis in the gastrointestinal tract of mice. Cancer Metastasis Rev 1992;11:179-95.
30. Kerr FJR, Winterford CM, Harmon BV. Apoptosis: its significance in cancer and cancer therapy. Cancer 1994;73:2013-26.
31. Bursch W, Grasl-Kraupp B. Active cell death: role in hepatocarcinogenesis and subtypes. Biochem Cell Biol 1994;72: 669-75.
32. Furuya H, Yabushita H, Noguchi M, Nakanishi M. Apoptosis and cell growth faction in normal, dysplastic, and neoplastic squamous epithelium of uterine cervix [Japanese]. Nippon Sanka Fujinka Gakkai Zasshi 1995;47:141-8.
33. Baretton GB, Diebold J, Christoforis G, Vogt M, Müller C, Dopfer K, et al. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance. Cancer 1996; 77:255-64.
34. Avery A, Paraskeva C, Hall P, Flanders KC, Sporn M, Moorghen M. TGF-β expression in the human colon: differential immunostaining along crypt epithelium. Br J Cancer 1993;68:137-9.
35. Koskiven PJ, Alitalo K. Role of myc amplification and overexpression in cell growth, differentiation, and death. Semin Cancer Biol 1993;4:3-12.